DEMONSTRATION OF INTERLEUKIN-6 IN MIDDLE-EAR EFFUSIONS

被引:2
|
作者
YELLON, RF
LEONARD, G
MARUCHA, P
SIDMAN, J
CARPENTER, R
BURLESON, J
CARLSON, J
KREUTZER, D
机构
[1] UNIV CONNECTICUT HLTH CTR, DEPT PATHOL, FARMINGTON, CT 06030 USA
[2] STAMFORD HOSP, DEPT SURG, STAMFORD, CT 06904 USA
[3] UNIV CONNECTICUT, CTR HLTH, DEPT SURG, DIV OTOLARYNGOL, FARMINGTON, CT 06032 USA
[4] UNIV CONNECTICUT, CTR HLTH, DEPT BEHAV SCI, FARMINGTON, CT 06032 USA
关键词
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
In response to infection in the middle ear, inflammatory cells produce cytokines-potent regulators and mediators of the immune response. In an earlier study, we demonstrated that levels of the cytokine interleukin 1 were higher in middle-ear effusions from younger children, while levels of the cytokine tumor necrosis factor were higher in middle-ear effusions from older children and in those requiring tympanostomy on multiple occasions. In this study, we evaluated middle-ear effusions for levels of the cytokine interleukin 6. Activities of interleukin 6 include stimulation of bone erosion and production of antibodies and fever. Using an enzyme-linked immunosorbent assay system, significant levels of interleukin 6 (>0.2 pg/mL) were found in 14 (36%) of 39 middle-ear effusions from 25 children with otitis media with effusion. The mean (+/-SE) level of interleukin 6 in middle-ear effusions was 173.9+/-74.7 pg/mg of total protein. Like interleukin 1, levels of interleukin 6 were higher in younger children. Tumor necrosis factor may be an important regulator of the local immune response in the middle-ear cleft during persistence of otitis media with effusion, while interleukin 1 and interleukin 6 may be important regulators during the early stages of otitis media with effusion.
引用
收藏
页码:745 / 748
页数:4
相关论文
共 50 条
  • [31] LYMPHOCYTE MORPHOLOGY IN MIDDLE-EAR EFFUSIONS
    PALVA, T
    HAYRY, P
    YLIKOSKI, J
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1980, 89 (03): : 143 - 146
  • [32] QUANTIFICATION OF BACTERIA IN MIDDLE-EAR EFFUSIONS
    STENFORS, LE
    RAISANEN, S
    ACTA OTO-LARYNGOLOGICA, 1988, 106 (5-6) : 435 - 440
  • [33] SCHOOL SCREENING FOR MIDDLE-EAR EFFUSIONS
    BROOKS, DN
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 223 - 228
  • [34] NEURAMINIDASE ACTIVITY IN MIDDLE-EAR EFFUSIONS
    LAMARCO, KL
    DIVEN, WF
    GLEW, RH
    DOYLE, WJ
    CANTEKIN, EI
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1984, 93 (01): : 76 - 84
  • [35] PROTEASE INHIBITORS IN MIDDLE-EAR EFFUSIONS
    CARLSSON, B
    LUNDBERG, C
    OHLSSON, K
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1981, 90 (01): : 38 - 41
  • [36] HISTAMINE LEVELS IN MIDDLE-EAR EFFUSIONS
    BERGER, G
    HAWKE, M
    PROOPS, DW
    RANADIVE, NS
    WONG, D
    ACTA OTO-LARYNGOLOGICA, 1984, 98 (5-6) : 385 - 390
  • [37] MIDDLE-EAR EFFUSIONS - DEFINITIONS AND TERMINOLOGY
    PAPARELLA, MM
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 8 - 11
  • [38] ANTIBACTERIAL THERAPY AND MIDDLE-EAR EFFUSIONS
    SHURIN, PA
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 250 - 253
  • [39] BIOCHEMICAL CHARACTERIZATION OF MIDDLE-EAR EFFUSIONS
    VERED, J
    SADE, J
    ELIEZER, N
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1972, 81 (03): : 394 - &
  • [40] MIDDLE-EAR EFFUSIONS - CURRENT CONCEPTS
    GREYDANUS, DE
    OCONNELL, EJ
    MCDONALD, TJ
    MAYO CLINIC PROCEEDINGS, 1977, 52 (08) : 497 - 503